Hillhouse-backed Genor Biopharma reaches $1.8b market cap in HK IPO

Hillhouse-backed Genor Biopharma reaches $1.8b market cap in HK IPO

Kowloon, Hong Kong. Photo: Shuja/Unsplash

07 October, 2020

Genor Biopharma Hillhouse Capital Temasek

Printed by Unregistered user on Sun, 27 Jul 2025 00:43:44 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Hillhouse-backed Genor Biopharma files for $320m HK IPO

Hillhouse leads $160m Series B funding in Chinese biopharma firm Genor

Read more from Greater China

Hong Kong IPO boom triggers price war among banks

Chinese e-commerce giants defend ‘instant retail’ strategy despite state pressure